PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
877.13%
Revenue growth of 877.13% while ACB.TO is flat. Bruce Berkowitz would check if a small edge can widen further.
177.09%
Gross profit growth of 177.09% while ACB.TO is zero. Bruce Berkowitz would see if minimal improvements could expand further.
-20.78%
Negative EBIT growth while ACB.TO is at 88.11%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-20.78%
Negative operating income growth while ACB.TO is at 158.15%. Joel Greenblatt would press for urgent turnaround measures.
83.07%
Net income growth comparable to ACB.TO's 87.63%. Walter Schloss might see both following similar market or cost trajectories.
83.25%
EPS growth at 75-90% of ACB.TO's 93.25%. Bill Ackman would push for improved profitability or share repurchases to catch up.
83.25%
Diluted EPS growth at 75-90% of ACB.TO's 93.33%. Bill Ackman would expect further improvements in net income or share count reduction.
0.59%
Share reduction more than 1.5x ACB.TO's 85.39%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.59%
Diluted share reduction more than 1.5x ACB.TO's 83.02%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
54.66%
Positive OCF growth while ACB.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
39.94%
FCF growth 75-90% of ACB.TO's 47.34%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1466.81%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-1466.81%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-1466.81%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-86.27%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-86.27%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-86.27%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
147.79%
Positive growth while ACB.TO is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
147.79%
Positive 5Y equity/share CAGR while ACB.TO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
147.79%
Positive short-term equity growth while ACB.TO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.22%
AR growth well above ACB.TO's 6.00%. Michael Burry fears inflated revenue or higher default risk in the near future.
92.35%
Inventory growth of 92.35% while ACB.TO is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-0.72%
Negative asset growth while ACB.TO invests at 4.18%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.67%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-68.21%
We cut SG&A while ACB.TO invests at 28.78%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.